Evidence map›Paper›PMID 24363464›Full record

ArticleSynthetic communications2014

IMPROVED SYNTHESIS OF 10-(2-ALKYLAMINO-2-OXOETHYL)-1,4,7,10-TETRAAZACYCLODODECANE-1,4,7-TRIACETIC ACID DERIVATIVES BEARING ACID-SENSITIVE LINKERS.

Bhumasamudram Jagadish, Tarik J Ozumerzifon, Sue A Roberts, Gabriel B Hall, Eugene A Mash, Natarajan Raghunand

Abstract read
In one paragraph

Article in Synthetic communications, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 7 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Bhumasamudram JagadishDepartment of Chemistry and Biochemistry, University of Arizona, Tucson, AZ 85721-0041 USA.
Tarik J OzumerzifonDepartment of Chemistry and Biochemistry, University of Arizona, Tucson, AZ 85721-0041 USA.
Sue A RobertsDepartment of Chemistry and Biochemistry, University of Arizona, Tucson, AZ 85721-0041 USA.
Gabriel B HallDepartment of Chemistry and Biochemistry, University of Arizona, Tucson, AZ 85721-0041 USA.
Eugene A MashDepartment of Chemistry and Biochemistry, University of Arizona, Tucson, AZ 85721-0041 USA.
Natarajan RaghunandDepartment of Medical Imaging, University of Arizona, Tucson, AZ 85721-0041 USA ; Arizona Cancer Center, University of Arizona, Tucson, AZ 85721-0041 USA.
University of Arizona · US

Funding

VITAMIN AP30CA023074 · NCI · UNIVERSITY OF ARIZONA · PI Dan Theodorescu · 1985 to 2026
$110.2M
Therapeutic Targeting of Hypoxic and Oxidative StressP01CA017094 · NCI · UNIVERSITY OF ARIZONA · PI GILLIES, ROBERT J. · 1985 to 2011
$13.7M
Redox-Sensitive & Blood-pool Contrast Agents for Magnetic Resonance ImagingR01CA118359 · NCI · UNIVERSITY OF ARIZONA · PI RAGHUNAND, NATARAJAN · 2006 to 2010
$1.0M
NCI NIH HHS P01 CA017094NCI NIH HHS P30 CA023074NCI NIH HHS R01 CA118359
6 · The paper itself

Abstract

Alkylation of the hydrobromide salts of 1,4,7-tris(methoxycarbonylmethyl)-1,4,7,10-tetraazacyclododecane and 1,4,7-tris(ethoxycarbonylmethyl)-1,4,7,10-tetraazacyclododecane with appropriate α-bromoacetamides, followed by hydrolysis, provides convenient access to 10-(2-alkylamino-2-oxoethyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triacetic acid derivatives that contain acid-sensitive functional groups. The utility of the method is demonstrated by improved syntheses of two known DOTA monoamides bearing acid-sensitive ω-tritylthio alkyl chains in much higher yields based on cyclen as the starting material.

Indexed as

CyclenDO3A monoamideDOTA monoamidemedical imagingsynthesis

Identifiers

PMID24363464
PMCPMC3866964
OpenAlexW2139941860

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.